Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Tocris Bioscience™ KRCA 0008

Potent Ack1 and ALK dual inhibitor; orally bioavailable

Supplier: Tocris Bioscience™ 5098/10

View more versions of this product

Catalog No. 50-981-0R

This item is not returnable. View return policy

Description

KRCA 0008 is a potent Ack1 and anaplastic lymphoma kinase (ALK) dual inhibitor (IC50 values are 4 and 12 nM respectively). Inhibits lung cancer H3122 cell proliferation (IC50 = 80 nM). Attenuates H3122 cell xenograft tumor growth in mice. Orally bioavailable.

Specifications

Purity	>99%
Product Type	KRCA 0008
Inhibitors	KRCA 0008

Quantity	10 mg
Molecular Weight (g/mol)	609.12

Product Suggestions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

Your Name

Email Address *

Type of Issue *

Detailed Description of Issue/Request *

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit

Your feedback has been submitted: Thank you for helping us improve our website.

For Research Use Only

Spot an opportunity for improvement?Share a Content Correction

Tocris Bioscience™ KRCA 0008

Description

Specifications

Product Suggestions

Documents

Promotions